29 related articles for article (PubMed ID: 12537102)
1. Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection.
Chamekh M; Vercruysse V; Habib M; Lorent M; Goldman M; Allaoui A; Vray B
Infect Immun; 2005 Oct; 73(10):6552-61. PubMed ID: 16177330
[TBL] [Abstract][Full Text] [Related]
2. Hydroxymethylnitrofurazone is active in a murine model of Chagas' disease.
Davies C; Marino Cardozo R; Sánchez Negrette O; Mora MC; Chung MC; Basombrío MA
Antimicrob Agents Chemother; 2010 Sep; 54(9):3584-9. PubMed ID: 20566772
[TBL] [Abstract][Full Text] [Related]
3. Infectivity, pathogenicity, and virulence of Trypanosoma cruzi Isolates from sylvatic animals and vectors, and domestic dogs from the United States in ICR strain mice and SD strain rats.
Roellig DM; Yabsley MJ
Am J Trop Med Hyg; 2010 Sep; 83(3):519-22. PubMed ID: 20810814
[TBL] [Abstract][Full Text] [Related]
4. Implications of Flagellar Attachment Zone Proteins TcGP72 and TcFLA-1BP in Morphology, Proliferation, and Intracellular Dynamics in
Souza-Melo N; de Lima Alcantara C; Vidal JC; Rocha GM; de Souza W
Pathogens; 2023 Nov; 12(11):. PubMed ID: 38003831
[TBL] [Abstract][Full Text] [Related]
5. Macrophages Promote Oxidative Metabolism To Drive Nitric Oxide Generation in Response to Trypanosoma cruzi.
Koo SJ; Chowdhury IH; Szczesny B; Wan X; Garg NJ
Infect Immun; 2016 Dec; 84(12):3527-3541. PubMed ID: 27698021
[TBL] [Abstract][Full Text] [Related]
6. A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.
Sánchez-Valdéz FJ; Pérez Brandán C; Ramírez G; Uncos AD; Zago MP; Cimino RO; Cardozo RM; Marco JD; Ferreira A; Basombrío MÁ
PLoS Negl Trop Dis; 2014 Feb; 8(2):e2696. PubMed ID: 24551259
[TBL] [Abstract][Full Text] [Related]
7. Knockout of the dhfr-ts gene in Trypanosoma cruzi generates attenuated parasites able to confer protection against a virulent challenge.
Perez Brandan C; Padilla AM; Xu D; Tarleton RL; Basombrio MA
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1418. PubMed ID: 22180798
[TBL] [Abstract][Full Text] [Related]
8. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.
Bhatia V; Garg NJ
Clin Vaccine Immunol; 2008 Aug; 15(8):1158-64. PubMed ID: 18550728
[TBL] [Abstract][Full Text] [Related]
9. Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi.
Zago MP; Barrio AB; Cardozo RM; Duffy T; Schijman AG; Basombrío MA
Infect Immun; 2008 Jan; 76(1):443-51. PubMed ID: 17938222
[TBL] [Abstract][Full Text] [Related]
10. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
[TBL] [Abstract][Full Text] [Related]
11. The targets of the lytic antibody response against Trypanosoma cruzi.
Krautz GM; Kissinger JC; Krettli AU
Parasitol Today; 2000 Jan; 16(1):31-4. PubMed ID: 10637586
[TBL] [Abstract][Full Text] [Related]
12. Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase chain reaction in mice.
Basombrío MA; Segura MA; Nasser JR
J Parasitol; 2002 Dec; 88(6):1107-12. PubMed ID: 12537102
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
Fernández MC; González Cappa SM; Solana ME
Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
[TBL] [Abstract][Full Text] [Related]
15. [Immunologic protection against Chagas disease. Independent effects upon infection, dissemination and lesions of Trypanosoma cruzi].
Basombrio MA; Mora MC; Segura MA
Medicina (B Aires); 1989; 49(3):191-6. PubMed ID: 2518641
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
